Literature DB >> 17890445

Altered uric acid levels and disease states.

Melinda K Kutzing1, Bonnie L Firestein.   

Abstract

Altered serum uric acid concentrations, both above and below normal levels, have been linked to a number of disease states. An abnormally high uric acid level has been correlated with gout, hypertension, cardiovascular disease, and renal disease, whereas a reduced uric acid concentration has been linked to multiple sclerosis, Parkinson's disease, Alzheimer's disease, and optic neuritis. Historically, uric acid has been considered a marker of these disease states. Recent studies, however, have provided evidence that uric acid may actually play a role in the development or progression of such diseases. As a result, the manipulation of uric acid concentrations is now either included in, or being investigated for, the treatment of a variety of disease states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890445     DOI: 10.1124/jpet.107.129031

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  89 in total

Review 1.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

2.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

Review 3.  A surprising role for uric acid: the inflammatory malaria response.

Authors:  Julio Gallego-Delgado; Maureen Ty; Jamie M Orengo; Diana van de Hoef; Ana Rodriguez
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

4.  Uric acid enhances longevity and endurance and protects the brain against ischemia.

Authors:  Roy G Cutler; Simonetta Camandola; Neil H Feldman; Jeong Seon Yoon; James B Haran; Sandro Arguelles; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2018-12-12       Impact factor: 4.673

5.  Self-sufficient control of urate homeostasis in mice by a synthetic circuit.

Authors:  Christian Kemmer; Marc Gitzinger; Marie Daoud-El Baba; Valentin Djonov; Jörg Stelling; Martin Fussenegger
Journal:  Nat Biotechnol       Date:  2010-03-28       Impact factor: 54.908

6.  Urinary Urea, Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients.

Authors:  Hanaa B Atya; Sahar A Ali; Mohamed I Hegazy; Fathia Z El Sharkawi
Journal:  Indian J Clin Biochem       Date:  2017-05-22

7.  Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

8.  Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Honglei Chen; Thomas H Mosley; Alvaro Alonso; Xuemei Huang
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

9.  A synthetic uric acid analog accelerates cutaneous wound healing in mice.

Authors:  Srinivasulu Chigurupati; Mohamed R Mughal; Sic L Chan; Thiruma V Arumugam; Akanksha Baharani; Sung-Chun Tang; Qian-Sheng Yu; Harold W Holloway; Ross Wheeler; Suresh Poosala; Nigel H Greig; Mark P Mattson
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

10.  Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients.

Authors:  Giuseppe Salemi; Maria Concetta Gueli; Francesco Vitale; Floriana Battaglieri; Egidio Guglielmini; Paolo Ragonese; Angela Trentacosti; Maria Fatima Massenti; Giovanni Savettieri; Antonino Bono
Journal:  Lipids Health Dis       Date:  2010-02-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.